Bruker Corporation (BRKR)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	4,249,900	3,819,600	3,857,000	3,763,900	3,611,800	3,336,900	3,384,800	3,550,700	3,650,000	3,127,700	3,087,000	3,034,900	3,049,000	2,879,400	2,943,400	2,961,900	2,771,500	2,352,100	2,349,700	2,242,500
Total stockholders’ equity	US$ in thousands	1,377,200	1,208,800	1,231,200	1,180,300	1,113,800	937,000	970,500	1,017,000	1,070,500	1,075,600	1,002,000	967,700	961,200	952,100	897,400	915,600	906,800	845,200	860,800	913,200
Financial leverage ratio		3.09	3.16	3.13	3.19	3.24	3.56	3.49	3.49	3.41	2.91	3.08	3.14	3.17	3.02	3.28	3.23	3.06	2.78	2.73	2.46

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $4,249,900K ÷ $1,377,200K
= 3.09

Bruker Corp's financial leverage ratio has shown some fluctuations over the past eight quarters. The ratio has ranged from 3.09 to 3.56, with the highest being in Q3 2022 and the lowest in Q4 2023.

A financial leverage ratio above 3 indicates that the company relies more on debt financing than equity financing to support its operations and growth. Bruker Corp's ratios have been consistently above 3, suggesting a relatively high level of financial leverage. This can enhance returns to equity shareholders when the business is performing well, but it also increases financial risk due to the obligations associated with debt repayment.

The decreasing trend from Q3 2022 to Q4 2023 could indicate that the company has been reducing its debt levels relative to equity, which may signify improved financial stability and lower risk in the long term.

Overall, further analysis into the reasons behind the fluctuations in the financial leverage ratio, including changes in debt levels and equity financing, would provide a more detailed understanding of Bruker Corp's capital structure and risk profile.